15353-j-veluchamy

1 General introduction and Scope of this Thesis | 27 14. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. The Journal of experimental medicine (1998) 187 (5):813-8. Epub 1998/03/28. PubMed PMID: 9480992; PubMed Central PMCID: PMCPMC2212178. 15. Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol (2011) 89 (2):216-24. Epub 2010/06/23. doi: 10.1038/ icb.2010.78. PubMed PMID: 20567250. 16. Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity (1997) 6 (6):655-61. Epub 1997/06/01. PubMed PMID: 9208838. 17. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. The Journal of experimental medicine (1998) 188 (12):2375-80. Epub 1998/12/22. PubMed PMID: 9858524; PubMed Central PMCID: PMCPMC2212426. 18. Krasnova Y, Putz EM, Smyth MJ, Souza-Fonseca-Guimaraes F. Bench to bedside: NK cells and control of metastasis. Clinical Immunology . doi: http://dx.doi.org/10.1016/j.clim.2015.10.001. 19. Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunology today (1990) 11 (7):237-44. Epub 1990/07/01. PubMed PMID: 2201309. 20. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 13 (2):133-44. 21. Rouas-Freiss N, Moreau P, Menier C, LeMaoult J, Carosella ED. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Seminars in cancer biology (2007) 17 (6):413- 21. Epub 2007/09/21. doi: 10.1016/j.semcancer.2007.07.003. PubMed PMID: 17881247. 22. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Sciences of the United States of America (1998) 95 (9):5199-204. Epub 1998/06/06. PubMed PMID: 9560253; PubMed Central PMCID: PMCPMC20238. 23. Schleypen JS, Von Geldern M, Weiss EH, Kotzias N, Rohrmann K, Schendel DJ, et al. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Int J Cancer (2003) 106 (6):905-12. Epub 2003/08/15. doi: 10.1002/ijc.11321. PubMed PMID: 12918068. 24. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. Journal of hepatology (2005) 43 (6):1013-20. Epub 2005/09/20. doi: 10.1016/j.jhep.2005.05.026. PubMed PMID: 16168521. 25. Hsia JY, Chen JT, Chen CY, Hsu CP, Miaw J, Huang YS, et al. Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma. Chang Gung medical journal (2005) 28 (5):335-40. Epub 2005/08/10. PubMed PMID: 16086548.